In the News


Fructose may beat other carbohydrates for lowering glycated blood proteins

Consuming fructose in place of other carbohydrates lowers glycated blood proteins by a clinically significant percentage, a recent meta-analysis suggests.

Pioglitazone associated with increased rates of bladder cancer

Pioglitazone was associated with an increased risk of bladder cancer, but rosiglitazone was not, in a large recent meta-analysis.

Possible link between thiazolidinediones, macular edema

Patients with type 2 diabetes who are treated with a thiazolidinedione may have an increased risk for diabetic macular edema, according to a recent study.

MKSAP Quiz: Hyperglycemia in a middle-aged man

This month's quiz asks readers to evaluate a 51-year-old man for a 9-month history of chronic abdominal pain.

Insulin doesn't appear to increase cancer or cardiovascular risk

Using basal insulin to normalize glucose levels in patients with early diabetes and pre-diabetes doesn't affect cardiovascular event or cancer rates, a study found.

Linagliptin non-inferior to glimepiride in two-year trial

Linagliptin was non-inferior to glimepiride in lowering hemoglobin A1c in type 2 diabetes patients, according to a study designed, conducted and analyzed by linagliptin's manufacturer, Boehringer Ingelheim.

Insulin injections, infusion pumps offer similar glucose control

Continuous insulin provides comparable glycemic control to injections, while continuous glucose monitoring is slightly superior to self-monitoring, a meta-analysis concluded.

Meta-analysis: Self-monitoring in non-insulin-treated type 2 diabetes improved HbA1c by 0.25%

A meta-analysis of randomized controlled trials of patients with non–insulin-treated type 2 diabetes found that six months of self-monitoring blood glucose reduced hemoglobin A1c levels by 0.25% more than usual care.

Tips to help patients remember oral medications

This month's tool offers tips on helping patients remember to take their medications.

New contraindication for aliskiren-containing medications

Aliskiren-containing medications are contraindicated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with diabetes.

Spotlight on bariatric surgery and diabetes

Several recent studies have analyzed the effects of bariatric surgery on diabetes and related complications.

Physician editor: David V. O'Dell, MD, FACP